In the treatment of lung cancer, Tarceva (also known as Erlotinib) and Iressa (also known as Gefitinib) are relatively new medications which have been a wonderfully welcome new addition to the weapons available to us in the fight against this difficult disease. A key question has been: What do we do when one of these agents stops working? Well, a group in Shizuoka, Japan, in a recent article published June 21, 2009 in the medical journal entitled Lung Cancer, has asked and has tried to answer exactly such a question.
Read information on:
There is a new test being developed which promises to help doctors find lung cancers at an early point in the growth of the cancer. If this test indeed is as successful as it promises to be, this could be an enormous breakthrough in the care and treatment of lung cancer.
Exciting news! There is a new drug for the treatment of Breast Cancer that is now being tested and is showing wonderfully promising results. In fact, the US Food and Drug administration has felt that the early results with the testing of this new medicine were so promising that it has granted this drug what is known as “FAST TRACK” approval.
When Prostate Cancer is initially discovered and it is found to be pretty much still located only in the prostate gland itself (in other words, it has not spread far into the body), there are basically three options that are available as treatment. The treatment that is chosen depends on A) how much cancer is found at the time of the initial diagnosis (which is known as the Stage of the cancer at the time of the initial diagnosis of cancer), B) the patient’s age at the time of the diagnosis, C) any other medical problems that he may have at the time of the finding of the Prostate Cancer, D) the aggressiveness of the cancer and E) the patient’s personal preferences.
One of the most important factors in the care and treatment of any form of cancer, is to know how much of the cancer is present at the time when the cancer is first discovered. The way that doctors are able to know and communicate with each other about much cancer is present at the time of the initial discovery is with something called a stage.
There is new cancer drug known as Abiraterone which has so far produced very encouraging results in the treatment of advanced Prostate Cancer. Prostate cancer is a very frequent form of cancer in our society. Each year 680,000 men worldwide are diagnosed with Prostate Cancer and as many as 220,000 will die of this disease. Numerous studies have proven that the hormone Testosterone stimulates the growth of Prostate Cancer and that inhibition of this hormone leads to a decrease in the size and the growth of Prostate Cancer.
Abiraterone, is a new medication which has the promise of treating Prostate Cancer by blocking an enzyme known as the CYP17 enzyme which plays a role in the production of Testosterone in men with Prostate Cancer.
The results of the treatments provided for men with advanced Prostate Cancer with this new medication are as yet preliminary, but they are very encouraging. This medication is now currently undergoing clinical trials and if all goes well, it is expected to be on the market in the year 2011. These concepts and many others are available in the Prostate Cancer audio CD which is available on the web site www.CancerInPlainEnglish.com
The history of the use of pink ribbons as a symbol for breast cancer dates back to the Komen Foundation’s Race for The Cure held in Washington, DC on June 16th, 1990. At that race, the Komen Foundation handed out pink visors and some participants wore pink ribbons during the event.
Colon cancer sometimes develops and provides no clues or signs that it is present until it has progressed far outside of the colon. Thankfully, however, colon cancer sometimes does give us “early warning clues” or signs indicating that a colon cancer is present. There are approximately 6 key symptoms and/or developments which may suggest to us that a person may have colon cancer. These symptoms or findings are as follows: